A case study on management of resistant hypertension and reduction of serum creatinine in a Chronic Kidney Disease patient through Vajedi Basti
1 Department of Kayachikitsa, M.A.M.’s Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar, Pune-411028, Maharashtra State, India.
2 M.A.M.’s Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar, Pune-411028, Maharashtra State, India.
Case Study
World Journal of Advanced Research and Reviews, 2023, 18(01), 635–639
Publication history:
Received on 01 March 2023; revised on 12 April 2023; accepted on 14 April 2023
Abstract:
Kidney diseases are prevalent due to changing life style, improper eating habits, hypertension and uncontrolled diabetes. According to modern science, the treatment for chronic kidney failure is haemodialysis or kidney transplant, both are quite expensive. Ayurveda plays an important role for finding effective and safe medicines to prevent kidney failure. A 38-year-old male patient diagnosed with Chronic Kidney Disease (CKD) and uncontrolled Hypertension (HTN) on three anti-hypertensive agents attended the OPD of Sane Guruji Arogya Kendra, Malwadi, Hadapsar Pune. The patient was initially kept on oral ayurvedic treatment for ten days. Then he was subjected to Basti Karma along with Sthanik Snehana-Swedana. After this therapy which continued for 21 days, it was found that the baseline blood pressure (180/110 mmHg) came down to 140/90 mmHg in the third week and serum creatin level ratio also reduced gradually. This therapy was provided along with allopathic medication as prescribed and patient was advised to continue allopathic medicine and to monitor BP regularly. After another 180 days monitoring, the patient had normal blood pressure along with a reduction in serum creatinine levels. From the results, it is concluded that this procedure is useful in resistant hypertension (RH), reducing the creatine level and in stabilizing and maintaining the blood pressure in a long run. Further study is recommended.
Keywords:
Panchakarma; Resistant Hypertension; Chronic Kidney Disease; Basti; Snehana-Swedana
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0